PATENT CLAIM ANALYSIS

Application Number: 15958295
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-08
Patent Classification: ["424", "246100"]

Abstract:
The present disclosure relates to branched and linear chimeric compounds containing both nucleic acid and non-nucleic acid moieties, as well as to polynucleotides. The present disclosure also relates to uses thereof for stimulating an immune response, and to methods for preparation of the branched chimeric compounds.

Claim (Index 53):
The method of  claim 49 , wherein the pharmaceutical composition is administered by intratumoral injection into a solid tumor of the mammalian subject.

Metadata:
- Claim Count in Document: 104.0
- Percentile: 91.0
- Lexical Diversity: 1.51515
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15004860', '15958292', '13349515', '11590150', '14030975']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7695940277109071
- 35 USC 102 Novelty (BERT): 0.6020648341870941
- Combined Prediction Score: 0.7528411083585258
- Mean Citation Score: 445.214108
- Max Citation Score: 722.6764
- Similarity Product: 422.6967587008713

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test